高级检索
当前位置: 首页 > 详情页

Identification of laryngeal carcinoma related gene 1 as a target gene of microRNA-21-5p in laryngeal carcinoma

| 认领 | 导出 |

文献详情

资源类型:
机构: [1]Univ South China, Sch Med, Inst Canc Res, Hengyang, Hunan, Peoples R China [2]Family Planning Res Inst Hunan Prov, Changsha, Hunan, Peoples R China
出处:
ISSN:

关键词: Laryngeal carcinoma related gene 1 tumor suppressor miR-21

摘要:
The laryngeal carcinoma related gene 1 (LCRG1) has been implicated as a tumor suppressor in laryngeal cancer. However, the microRNAs (small non-coding RNAs of approximately 22 nucleotides in length) that regulate LCRG1 expression remain elusive. In this study, quantitative PCR analysis first showed that the average level of miR-21-5p was elevated in primary laryngeal carcinoma tissues compared to paired adjacent non-tumor tissues. Thus, we explored the potential regulation of miR-21-5p on LCRG1. PITA algorithm predicted that two sites within LCRG1 mRNA 3'UTR, which reside at +743 position and +938 position, respectively, might be targeted by miR-21-5p. Dual luciferase reporter assay confirmed that miR-21-5p mimic specifically decreased luciferase activity of the reporter harboring 3'UTR+743 target site. With respect to the 3'UTR+938 site, the influence of miR-21-5p on luciferase activity was not sequence specific. Further, we observed that miR-21-5p mimic transfection decreased the LCRG1 protein in human laryngeal carcinoma Hep2 cells as indicated by Western blotting analysis, and promoted cell growth, migration and invasion as evidenced by MTT assay and transwell migration assay and matrigel invasion assay. Of note, the effects of miR-21-5p inhibitor treatment are opposite to those of the miR-21-5p mimic. Taken together, this study identifies that the tumor suppressor LCRG1 is targeted by the oncogenic miR-21-5p. This finding may help us to better understand the dysregulation of cancer-associated genes associated with microRNAs and eventually improve the diagnosis and target therapy for laryngeal carcinoma.

基金:
语种:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 肿瘤学 4 区 病理学
最新[2023]版:
第一作者:
第一作者机构: [1]Univ South China, Sch Med, Inst Canc Res, Hengyang, Hunan, Peoples R China
通讯作者:
通讯机构: [2]Family Planning Res Inst Hunan Prov, Changsha, Hunan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号